BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 98 filers reported holding BIOXCEL THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $250,869 | -78.1% | 37,668 | -38.7% | 0.00% | – |
| Q1 2023 | $1,146,282 | +76883.3% | 61,432 | -11.4% | 0.00% | – |
| Q4 2022 | $1,489 | -99.8% | 69,320 | -6.8% | 0.00% | – |
| Q3 2022 | $878,000 | -57.6% | 74,349 | -52.6% | 0.00% | -100.0% |
| Q2 2022 | $2,072,000 | -20.9% | 156,980 | +25.3% | 0.00% | 0.0% |
| Q1 2022 | $2,620,000 | +342.6% | 125,280 | +330.5% | 0.00% | – |
| Q4 2021 | $592,000 | – | 29,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 40,000 | $836,000 | 1.01% |
| ACT CAPITAL MANAGEMENT, LLC | 20,000 | $418,000 | 0.44% |
| Knoll Capital Management, LLC | 20,000 | $418,000 | 0.26% |
| Artemis Investment Management LLP | 1,428,228 | $29,855,000 | 0.24% |
| Rubric Capital Management LP | 268,528 | $5,615,000 | 0.20% |
| Virtus ETF Advisers LLC | 7,713 | $161,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 107,700 | $2,252,000 | 0.05% |
| PDT Partners, LLC | 28,031 | $586,000 | 0.05% |
| AllSquare Wealth Management LLC | 3,162 | $66,000 | 0.04% |
| Hennion & Walsh Asset Management, Inc. | 35,221 | $736,000 | 0.04% |